7654465111

List of Trials

Send Us A Message

Have questions for us? Contact us to find out more.

  • This field is for validation purposes and should be left unchanged.

Non-Small Cell lung cancer and triple negative breast cancer

April 12, 2019

  • Pfizer C3621001- A Phase 1 Study to evaluate the safety, pharmacokinetics, and pharmacodynamics of escalating doses and treatment intensification of a vaccine-based immunotherapy regimen-2 (VBIR-2) (PF-06936308) for advanced Non-Small Cell lung cancer and metastatic triple-negative breast cancer.